Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2017-08-19 2017-08-19
Drug Identification Number 02393034 02393034
Brand name NALOXONE HYDROCHLORIDE INJECTION NALOXONE HYDROCHLORIDE INJECTION
Common or Proper name Naloxone Hydrochloride Injection Naloxone Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1mL vial 1mL vial
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date 2017-08-18 2017-08-18
Actual discontinuation date 2017-08-18 2017-08-18
Remaining supply date 2017-08-18 2017-08-18
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Replaced by DIN number 02455935 (Ethical) Replaced by DIN number 02455935 (Ethical)
Health Canada comments